Home/Pipeline/OmniVu™ Lens System

OmniVu™ Lens System

Cataract surgery / Presbyopia correction

Feasibility StudyActive

Key Facts

Indication
Cataract surgery / Presbyopia correction
Phase
Feasibility Study
Status
Active
Company

About Atia Vision

Atia Vision, founded in 2016 and based in Campbell, California, is a private ophthalmic device innovator focused on the large unmet need in cataract surgery. Its lead product, the OmniVu™ IOL, is a dual-optic, fluid-filled lens designed to restore natural accommodation, potentially offering superior near-to-distance vision without the side effects of current premium lenses. The company achieved a critical milestone in May 2025 with FDA IDE approval to begin a U.S. feasibility study, supported by a $42M Series E financing round closed in 2022.

View full company profile

Therapeutic Areas